Apollo Medical Holdings Inc
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health … Read more
Apollo Medical Holdings Inc (3AM) - Net Assets
Latest net assets as of September 2025: €554.72 Million EUR
Based on the latest financial reports, Apollo Medical Holdings Inc (3AM) has net assets worth €554.72 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.24 Billion) and total liabilities (€1.68 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €554.72 Million |
| % of Total Assets | 24.8% |
| Annual Growth Rate | 3.99% |
| 5-Year Change | 15.5% |
| 10-Year Change | N/A |
| Growth Volatility | 18.72 |
Apollo Medical Holdings Inc - Net Assets Trend (2018–2024)
This chart illustrates how Apollo Medical Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Apollo Medical Holdings Inc (2018–2024)
The table below shows the annual net assets of Apollo Medical Holdings Inc from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €514.17 Million | +25.17% |
| 2023-12-31 | €410.77 Million | -26.46% |
| 2022-12-31 | €558.55 Million | +9.38% |
| 2021-12-31 | €510.64 Million | +14.71% |
| 2020-12-31 | €445.15 Million | +23.29% |
| 2019-12-31 | €361.06 Million | -11.21% |
| 2018-12-31 | €406.66 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Apollo Medical Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1509.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €286.28 Million | 40.17% |
| Other Components | €426.44 Million | 59.83% |
| Total Equity | €712.72 Million | 100.00% |
Apollo Medical Holdings Inc Competitors by Market Cap
The table below lists competitors of Apollo Medical Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xiamen Meiya Pico Information
SHE:300188
|
$820.69 Million |
|
Bic Camera Inc
F:1U3
|
$821.82 Million |
|
Tianneng Battery Group Co Ltd
SHG:688819
|
$821.98 Million |
|
GemVax&KAEL Co.Ltd
KQ:082270
|
$822.25 Million |
|
Tellurian Inc
F:MPLN
|
$820.47 Million |
|
Viad Corp
NYSE:VVI
|
$820.17 Million |
|
National Beverage Corp
NASDAQ:FIZZ
|
$820.06 Million |
|
Thai Union Group PCL
BK:TU
|
$820.04 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Apollo Medical Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 614,218,000 to 712,720,000, a change of 98,502,000 (16.0%).
- Net income of 43,149,000 contributed positively to equity growth.
- Dividend payments of 4,036,000 reduced retained earnings.
- Share repurchases of 937,000 reduced equity.
- Other factors increased equity by 60,326,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €43.15 Million | +6.05% |
| Dividends Paid | €4.04 Million | -0.57% |
| Share Repurchases | €937.00K | -0.13% |
| Other Changes | €60.33 Million | +8.46% |
| Total Change | €- | 16.04% |
Book Value vs Market Value Analysis
This analysis compares Apollo Medical Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.43x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.06x to 1.43x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €5.22 | €21.20 | x |
| 2019-12-31 | €5.33 | €21.20 | x |
| 2020-12-31 | €7.83 | €21.20 | x |
| 2021-12-31 | €10.04 | €21.20 | x |
| 2022-12-31 | €11.65 | €21.20 | x |
| 2023-12-31 | €13.11 | €21.20 | x |
| 2024-12-31 | €14.87 | €21.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Apollo Medical Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.05%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.12%
- • Asset Turnover: 1.50x
- • Equity Multiplier: 1.90x
- Recent ROE (6.05%) is below the historical average (7.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 6.00% | 2.11% | 1.00x | 2.84x | €-7.22 Million |
| 2019 | 11.24% | 3.24% | 0.91x | 3.80x | €2.37 Million |
| 2020 | -7.18% | -6.42% | 0.45x | 2.47x | €-56.83 Million |
| 2021 | 15.38% | 8.91% | 0.89x | 1.94x | €24.11 Million |
| 2022 | 8.33% | 3.95% | 1.18x | 1.78x | €-9.09 Million |
| 2023 | 9.89% | 4.38% | 1.49x | 1.52x | €-704.80K |
| 2024 | 6.05% | 2.12% | 1.50x | 1.90x | €-28.12 Million |
Industry Comparison
This section compares Apollo Medical Holdings Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,657,181,831
- Average return on equity (ROE) among peers: 7.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Apollo Medical Holdings Inc (3AM) | €554.72 Million | 6.00% | 3.03x | $820.67 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |